Static Chart Alector, Inc.

Stocks

Real-time Estimate Cboe BZX 14:21:52 2026-10-07 EDT			5-day change	1st Jan Change
1.865 ^USD	+3.04%		+0.27%	+18.91%

10-05	Alector Shares Rise After Licensing AL050 Program to Roche's Genentech	MT
10-05	Alector, Inc. And Genentech, Inc. Enter Global License Agreement For Brain Penetrant GCase Enzyme Replacement Therapy For Parkinsons Disease And Other Neurodegenerative Diseases	CI

Duration

Period